Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Dirk Wyndaele"'
Autor:
Dirk Wyndaele
Publikováno v:
Tijdschrift voor Urologie. 10:131-140
SamenvattingHet arsenaal aan levensverlengende systemische behandelingen voor gemetastaseerd castratieresistent prostaatcarcinoom (mCRPC) is de afgelopen jaren uitgebreid met radium-223 (Ra-223), abirateron, enzalutamide en cabazitaxel. Ra-223 is sin
Publikováno v:
Diagnostics
Diagnostics; Volume 11; Issue 6; Pages: 1100
Diagnostics, Vol 11, Iss 1100, p 1100 (2021)
Diagnostics; Volume 11; Issue 6; Pages: 1100
Diagnostics, Vol 11, Iss 1100, p 1100 (2021)
Rationale: To formally determine the repeatability of Ga-68 PSMA lesion uptake in both relapsing and metastatic tumor. In addition, it was hypothesized that the BPL algorithm Q. Clear has the ability to lower SUV signal variability in the small lesio
Autor:
Jean-Paul A. van Basten, A.J.W. Beulens, Mark J. Roef, R.J. Hoekstra, Dirk Wyndaele, Diederik M. Somford, Lenneke J M Brouwer, Eric Vrijhof, Michiel Sedelaar
Publikováno v:
Nuclear Medicine Communications, 42, 5, pp. 476-481
Nuclear Medicine Communications, 42, 476-481
Nuclear Medicine Communications, 42, 476-481
Item does not contain fulltext INTRODUCTION: To determine preoperative diagnostic accuracy of 18F-fluciclovine PET/CT-scan in detection (or exclusion) of lymph node metastases (LNM) in men with prostate cancer (PCa) in comparison to the histopatholog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90ed73d32c12286cfec577ba9c3cc49b
https://repository.ubn.ru.nl/handle/2066/245039
https://repository.ubn.ru.nl/handle/2066/245039
Purpose To formally determine the repeatability of 68Ga-PSMA lesion uptake in both relapsing and metastatic tumour. In addition, it was hypothesized that the Bayesian penalized likelihood algorithm Q.Clear has the ability to lower SUV signal variabil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7adbe589df9ae5c50961b417590d93a5
https://doi.org/10.21203/rs.3.rs-68827/v1
https://doi.org/10.21203/rs.3.rs-68827/v1
Autor:
Claudine de Meijer, Dirk Wyndaele, Walter Noordzij, Pieter van den Berg, Agni Baka, Annemarie M. Leliveld-Kors, Joan van den Bosch, Michel L. Peters, Jennifer G. Gaultney
Publikováno v:
Applied Health Economics and Health Policy, 16(1), 133-143. Springer International Publishing AG
BACKGROUND: The treatment of metastatic castration-resistant prostate cancer has changed with the introduction of radium-223, cabazitaxel, abiraterone and enzalutamide. To assess value for money, their cost effectiveness in patients with metastatic c
Autor:
J-P. Van Basten, Mark J. Roef, A.J.W. Beulens, J.P.M. Sedelaar, L.J.M. Brouwer, D.M. Somford, R.J. Hoekstra, Dirk Wyndaele, H.J.E.J. Vrijhof
Publikováno v:
European Urology Open Science, Vol 21, Iss, Pp S11-(2020)
Autor:
Joe M. O'Sullivan, Felix M. Mottaghy, Dirk Wyndaele, Jann Mortensen, Alexander Haug, Kalevi Kairemo, Irene Virgolini, Francis Sundram, Wim J.G. Oyen, Val Lewington, Hanna Mäenpää
Publikováno v:
The Journal of OncoPathology. 3:1-25
Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer
Autor:
Dirk Wyndaele, Agni Baka, Jennifer G. Gaultney, Pieter van den Berg, Annemarie M. Leliveld-Kors, Michel L. Peters, Joan van den Bosch, Walter Noordzij, Claudine de Meijer
Publikováno v:
Applied Health Economics and Health Policy
Background The treatment of metastatic castration-resistant prostate cancer has changed with the introduction of radium-223, cabazitaxel, abiraterone and enzalutamide. To assess value for money, their cost effectiveness in patients with metastatic ca
Autor:
Annemarie M. Leliveld-Kors, Jennifer G. Gaultney, Walter Noordzij, Dirk Wyndaele, Agni Baka, C. De Meijer
Publikováno v:
University of Groningen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f43f3b19a0f8a5b740b2d98254098291
https://research.rug.nl/en/publications/9eed9d78-9f40-4cab-9c21-4ec8be8bdd60
https://research.rug.nl/en/publications/9eed9d78-9f40-4cab-9c21-4ec8be8bdd60